ANALOGUES DE PEPTIDE 2 DU TYPE GLUCAGON

European patent · EP0906338 · Deleted

Register entry

Publication number
EP0906338
Application number
EP97916280
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Apr 11, 1997
Published
Apr 7, 1999
Granted
Nov 6, 2002
Deleted
Apr 10, 2017
Reason
Maximum term reached
IPC classes
C07K 14/605 (2006.01)
A61K 38/26 (2006.01)
G01N 33/68 (2006.01)
Priority
US 631273 12.04.1996
PCT application
PCT/CA1997/000252 11.04.1997
PCT publication
WO1997/039031 23.10.1997
Filing language
English
Source
Swissreg

Supplementary protection certificates

A certificate extends the patent’s protection for a medicine or a plant protection product authorised in Switzerland.

Teduglutide

C00906338/01 · Medicine · Granted · Protection from Apr 11, 2017 to Apr 10, 2022

Authorisation 65739 (Swissmedic, Sep 1, 2016)

Deleted, Maximum term reached

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 18, 2017

    Maximum term reached

    Published in Swissreg on 18.04.2017

  2. Feb 6, 2013

    Transferred

    Owner
    1149336 ONTARIO INC., 19 Fernwood Road, Toronto,, Ontario M6B 3G3, Canada, 1506385 Alberta Ltd., 1000, 400 -3RD Avenue SW, Calgary, Alberta T2P 4H2, Canada → 1149336 ONTARIO INC., 19 Fernwood Road, Toronto,, Ontario M6B 3G3, Canada, NPS Pharmaceuticals Inc., 550 Hills Drive, 3rd Floor, Bedminster, NJ 07921, USA

    Published in Swissreg on 06.02.2013

  3. Feb 6, 2013

    Agent entered

    Representative
    Meyerlustenberger Lachenal, Forchstrasse 452, Postfach 1432, 8032 Zürich

    Published in Swissreg on 06.02.2013

  4. Feb 5, 2013

    Address changed

    Owner
    1149336 ONTARIO INC., 19 Fernwood Road, Toronto,, Ontario M6B 3G3, Canada, NPS Allelix Corp., 6850 Goreway Drive, Mississauga, Ontario L4V 1V7, Canada → 1149336 ONTARIO INC., 19 Fernwood Road, Toronto,, Ontario M6B 3G3, Canada, 1506385 Alberta Ltd., 1000, 400 -3RD Avenue SW, Calgary, Alberta T2P 4H2, Canada

    Published in Swissreg on 05.02.2013

  5. Sep 15, 2003

    Address changed

    Owner
    1149336 ONTARIO INC., 19 Fernwood Road, Toronto,, Ontario M6B 3G3, Canada, Allelix Biopharmaceuticals Inc., 6850 Goreway Drive, Mississauga,, Ontario, L4V 1V7, Canada → 1149336 ONTARIO INC., 19 Fernwood Road, Toronto,, Ontario M6B 3G3, Canada, NPS Allelix Corp., 6850 Goreway Drive, Mississauga, Ontario L4V 1V7, Canada

    Published in +pat+ No 17 in 2003

  6. Sep 15, 2003

    Agent entered

    Representative
    R. A. Egli & Co., Patentanwälte, Horneggstrasse 4, 8008 Zürich

    Published in +pat+ No 17 in 2003

  7. Nov 15, 2002

    Granted

    Published in +pat+ No 21 in 2002

Parties

Holder

1149336 ONTARIO INC.

19 Fernwood Road, Toronto, Ontario M6B 3G3, CA

NPS Pharmaceuticals, Inc.

NPS Pharmaceuticals Inc.

550 Hills Drive, 3rd Floor, Bedminster, NJ 07921, US

Agent

Meyerlustenberger Lachenal

Forchstrasse 452 Postfach 1432, 8032 Zürich

Inventor

DRUCKER, Daniel, J.

Toronto, Ontario M6B 3G3, CA

CRIVICI, Anna, E.

Toronto, Ontario M6H 3B5, CA

SUMNER-SMITH, Martin

Bolton, Ontario L7E 3V4, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.